Study Title
 |
Principal
Investigator |
Disease
Category |
 |
|
An Efficacy and Safety Study of Somatuline Depot (Lanreotide) Injection to Treat Carcinoid Syndrome
|
George Albert Fisher M.D. Ph.D.
|
Carcinoid Tumor
|
|
|
A Phase 1 Dose Escalation Study of OMP-21M18 in Subjects With Solid Tumors
|
Branimir I Sikic
|
Carcinomas (including Squamous Cell and Adenocarcinoma)
|
|
|
Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy
|
Irene L. Wapnir
|
Breast Cancer
Carcinoma, Intraductal, Noninfiltrating
|
|
|
Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia
|
Peter L Greenberg
|
Leukemia
Carcinomas (including Squamous Cell and Adenocarcinoma)
Myelodysplastic Syndromes
|
|
|
Safety and Toxicity Study of Sorafenib in Patients With Kidney Cancer
|
Dr. Sandy Srinivas
|
Kidney Diseases
Carcinoma, Renal Cell
|
|
|
Pre-Surgical Detection of Clear Cell Renal Cell Carcinoma Using Radiolabeled G250-Antibody
|
Benjamin I. Chung
|
Kidney Neoplasms
Carcinoma, Renal Cell
|
|
|
A Phase 1/2 Study of Aflibercept Administered in Combination with Pemetrexed and Cisplatin in Patients with Advanced Carcinoma
|
Heather A. Wakelee
|
Carcinoma, Non-Small-Cell Lung
|
|
|
Phase II, Multi-Center, Single-Arm, Two-Cohort Trial of GDC-0449 for Advanced Basal Cell Carcinoma
|
Anthony Oro
Dr. Anne Lynn S. Chang
|
Carcinoma, Basal Cell
Skin Cancers
|
|
|
A Study of XL184 With or Without Erlotinib in Adults With Non-Small Cell Lung Cancer
|
Heather A. Wakelee
|
Carcinoma, Non-Small-Cell Lung
|
|
|
Study of XL880 in Subjects With Papillary Renal Cell Carcinoma
|
Dr. Sandy Srinivas
|
Carcinoma, Papillary
Kidney Neoplasms
Carcinoma, Renal Cell
|
|
|
Study of XL518 in Adults With Solid Tumors
|
Branimir I Sikic
|
Carcinomas (including Squamous Cell and Adenocarcinoma)
|
|
|
Sunitinib or Sorafenib in Treating Patients With Kidney Cancer That Was Removed By Surgery
|
Dr. Sandy Srinivas
|
Kidney Neoplasms
Carcinoma, Renal Cell
|
|
|
Cisplatin and Radiation Therapy With or Without Tirapazamine in Treating Patients With Cervical Cancer
|
Amreen Husain
|
Uterine Neoplasms
Uterine Cervical Neoplasms
Adenocarcinoma
Carcinoma, Squamous Cell
|
|
|
Phase II Lapatinib and Radiation for Stage III-IV Head and Neck Cancer Patients Who Cannot Tolerate Concurrent Chemotherapy
|
Quynh-Thu Le
|
Head and Neck Cancer
Carcinoma, Squamous Cell
|
|
|
Temsirolimus and Sorafenib as Second-Line Therapy in Patients With Advanced RCC Who Failed First-Line Sunitinib
|
Dr. Sandy Srinivas
|
Kidney Neoplasms
Carcinoma, Renal Cell
|
|
|
BIBW 2992 in Head&Neck Cancer
|
Dr. A. Dimitrios Colevas
|
Head and Neck Cancer
Carcinoma, Squamous Cell
|
|
|
Phase 1 Trial of Oral Ixabepilone
|
Branimir I Sikic
|
Carcinomas (including Squamous Cell and Adenocarcinoma)
|
|
|
A Phase 1 Study of an Oral VEGFR Inhibitor (AV-951) in Combination With Torisel in Renal Cell Cancer
|
Dr. Sandy Srinivas
|
Carcinoma, Renal Cell
|
|
|
Evaluating Sunitinib Therapy in Renal Cell Carcinoma Using F-18 FDG PET/CT and DCE MRI
|
Dr Andrew Quon
|
Kidney Neoplasms
Carcinoma, Renal Cell
|
|
Study Title
|
Principal
Investigator |
Disease
Category |
|
Perception of Burden, Uncertainty and Symptomatology in Caregivers of BMT Patients
(No longer recruiting)
|
Katherine Tierney
|
Carcinomas (including Squamous Cell and Adenocarcinoma)
|
|
Study of TAC-101 as Second Line Treatment in Patients With Advanced Hepatocellular Carcinoma Who Received Sorafenib as First Line Therapy
(Terminated)
|
Samuel So
|
Carcinoma, Hepatocellular
|
|
Study of XL647 in Subjects With NSCLC Who Have Progressed After Responding to Treatment With Gefitinib or Erlotinib
(No longer recruiting)
|
Heather A. Wakelee
|
Carcinoma, Non-Small-Cell Lung
|
|
A Study of Enzastaurin and Erlotinib in Patients With Solid Tumors and Lung Cancer
(No longer recruiting)
|
Heather A. Wakelee
|
Carcinoma, Non-Small-Cell Lung
Lung Diseases
Carcinomas (including Squamous Cell and Adenocarcinoma)
Thoracic Neoplasms
Neoplasms, Glandular and Epithelial
Lung Cancer
|
|
Safety and Efficacy Clinical Study of SNS-595 in Patients With Advanced Small Cell Lung Cancer
(Completed)
|
Heather A. Wakelee
|
Carcinoma, Small Cell
|
|
A Phase 2 Clinical Trial of the Effectiveness of IRX-2 in Treating Patients With Operable Head and Neck Cancer
(No longer recruiting)
|
Dr Michael Kaplan
|
Head and Neck Cancer
Carcinoma, Squamous Cell
|
|
Evaluation of Stereotactic Radiosurgery For Liver Malignancies
(Completed)
|
Albert Koong
|
Cholangiocarcinoma
Liver Cancer
Adenocarcinoma
|
|
Phase I Dose Escalation of Stereotactic Radiosurgical Boost for Locally Advanced Esophageal Cancer
(No longer recruiting)
|
Daniel T Chang
|
Esophageal Neoplasms
Adenocarcinoma
Carcinoma, Squamous Cell
|
|
Cisplatin and ZD1839 + Re-Irradiation in Recurrent Squamous Cell Cancer of the Head and Neck
(Completed)
|
Quynh-Thu Le
|
Head and Neck Cancer
Carcinoma, Squamous Cell
|
|
Cervical Nodal Mets in Squamous Cell Carcinoma of H&N - MRI, FDG-PET, & Histopathologic Correlation
(No longer recruiting)
|
Quynh-Thu Le
Dr. Billy W. Loo Jr. M.D. Ph.D.
|
Head and Neck Cancer
Carcinoma, Squamous Cell
|
|
Accelerated Partial Breast Irradiation Following Lumpectomy for Breast Cancer
(No longer recruiting)
|
Frederick M. Dirbas
|
Breast Cancer
Carcinoma, Ductal
|
|
First-Line Treatment of Advanced Bladder Cancer Randomized vs. Gemcitabine ± Vinflunine in Patients Ineligible to Receive Cisplatin-Based Therapy
(Completed)
|
Dr. Sandy Srinivas
|
Carcinoma, Transitional Cell
Bladder Cancer
|
|
Correlation of PET-CT Studies with Serum Protein Analysis
(Completed)
|
Dr Andrew Quon
|
Carcinomas (including Squamous Cell and Adenocarcinoma)
|
|
A Study Evaluating the Efficacy and Safety of Sutinib With or Without Bevacizumab in First-Line Patients With Metastatic Renal Cell Cancer (SABRE-R)
(No longer recruiting)
|
Dr. Sandy Srinivas
|
Kidney Neoplasms
Carcinoma, Renal Cell
|
|
Safety and Tolerability Study of SNS-314 for Advanced Solid Tumors
(Completed)
|
Ranjana Hira Advani
|
Carcinomas (including Squamous Cell and Adenocarcinoma)
|
|
Phase 2 Study of GSK1363089 (Formerly XL880) in Adults With Squamous Cell Cancer of the Head and Neck
(Completed)
|
Dr. A. Dimitrios Colevas
|
Head and Neck Cancer
Carcinoma, Squamous Cell
|
|
Trial Administration